Herbst A - Search Results

1

Dual target dilemma: navigating epcoritamab vs. glofitamab in relapsed refractory diffuse large B-cell lymphoma.

Davis JA, Granger K, Sakowski A, Goodwin S, Herbst A, Smith D, Hendrickson L, Nachar VR. Davis JA, et al. Among authors: herbst a. Expert Rev Hematol. 2023 Jul-Dec;16(12):915-918. doi: 10.1080/17474086.2023.2285978. Epub 2023 Dec 18. Expert Rev Hematol. 2023. PMID: 37982732 No abstract available.

2

Gastric adenocarcinoma following CD19-directed chimeric antigen receptor T cell therapy.

Davis JA, Misniakiewicz J, Hendrickson L, McGann M, Herbst A, Hess BT. Davis JA, et al. Among authors: herbst a. Ann Hematol. 2023 Feb;102(2):461-462. doi: 10.1007/s00277-022-05045-w. Epub 2022 Nov 16. Ann Hematol. 2023. PMID: 36385650 No abstract available.

3

Polatuzumab Vedotin for the Front-Line Treatment of Diffuse Large B-Cell Lymphoma: A New Standard of Care?

Davis JA, Shockley A, Herbst A, Hendrickson L. Davis JA, et al. Among authors: herbst a. J Adv Pract Oncol. 2023 Jan;14(1):67-72. doi: 10.6004/jadpro.2023.14.1.6. Epub 2023 Feb 1. J Adv Pract Oncol. 2023. PMID: 36741209 Free PMC article.

4

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies.

Davis JA, Granger K, Roubal K, Smith D, Gaffney KJ, McGann M, Cendagorta A, Thurlapati A, Herbst A, Hendrickson L, Hashmi H, Hess BT. Davis JA, et al. Among authors: herbst a. Blood. 2023 Jan 12;141(2):200-203. doi: 10.1182/blood.2022018283. Blood. 2023. PMID: 36332185 Free PMC article.

5

Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.

Thurlapati A, McGann M, Davis JA, Granger K, Roubal K, Smith D, Gaffney KJ, Cendagorta A, Herbst A, Hendrickson L, Hess BT, Hashmi H. Thurlapati A, et al. Among authors: herbst a. J Med Virol. 2023 Aug;95(8):e29027. doi: 10.1002/jmv.29027. J Med Virol. 2023. PMID: 37548241 No abstract available.

6

Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Davis JA, Rizzieri DA, Lane AA, Taylor J, Faisal MS, Vasu S, Soong D, Li H, Herbst A, Greenwell IB. Davis JA, et al. Among authors: herbst a. Leuk Lymphoma. 2022 Nov;63(11):2757-2759. doi: 10.1080/10428194.2022.2090552. Epub 2022 Jun 21. Leuk Lymphoma. 2022. PMID: 35727174 No abstract available.

7

Chimeric mitochondrial RNA transcripts predict mitochondrial genome deletion mutations in mitochondrial genetic diseases and aging.

Vandiver AR, Herbst A, Stothard P, Wanagat J. Vandiver AR, et al. Among authors: herbst a. Genome Res. 2024 Nov 27:gr.279072.124. doi: 10.1101/gr.279072.124. Online ahead of print. Genome Res. 2024. PMID: 39603705

8

Veterans' Lung Cancer Risk Conceptualizations versus Lung Cancer Screening Shared Decision-Making Conversations with Clinicians: A Qualitative Study.

Boudreau JH, Bolton RE, Núñez ER, Caverly TJ, Kearney L, Sliwinski S, Herbst AN, Slatore CG, Wiener RS. Boudreau JH, et al. Among authors: herbst an. Med Decis Making. 2025 Jan;45(1):86-96. doi: 10.1177/0272989X241292643. Epub 2024 Nov 22. Med Decis Making. 2025. PMID: 39575828

9

Demographics and health of U.S. senior horses used in competitions.

Herbst AC, Coleman MC, Macon EL, Harris PA, Adams AA. Herbst AC, et al. Equine Vet J. 2024 Nov 12. doi: 10.1111/evj.14438. Online ahead of print. Equine Vet J. 2024. PMID: 39533744

10

Calcium propionate is an alkalizing agent in exercising Standardbreds.

Herbst AC, Puglia AT, Malinowski K, McKeever KH. Herbst AC, et al. J Equine Vet Sci. 2024 Dec;143:105212. doi: 10.1016/j.jevs.2024.105212. Epub 2024 Oct 29. J Equine Vet Sci. 2024. PMID: 39481462

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

497 results

Search Page

Filters